This study looked at post-stroke epilepsy, defined here as one or more seizures occurring more than 7 days after a stroke.
This paper is a topical review, not a new experiment.
This paper was a scoping review, which means the authors gathered and summarized existing research rather than running one new experiment.
This study looked at add-on treatment with perampanel in very young children with drug-resistant epilepsy.
Researchers studied 3 families with epilepsy from a highly consanguineous population.
This paper was a systematic review, which means the authors searched past medical reports and retrospective case series to look for patterns.
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
Researchers combined results from randomized, double-blind studies that tested two add-on seizure medicines, lacosamide (LCM) and brivaracetam (BRV), in adults and older teens with drug-resistant focal epilepsy.
This report describes one premature newborn boy in the Netherlands who had hard-to-control seizures.